Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Appliance of science

- PMLiVE

Beyond Engagement: Creating Medical Education with Measurable Results

Want to truly engage and educate HCPs? Learn to avoid costly mistakes and be at the forefront of learning by creating a dynamic platform that captures their attention and drives...

Impetus Digital

- PMLiVE

Uniphar Secures 10th Cell and Gene Therapy Project

[Dublin, April 17th 2025] Uniphar, a global leader in pharmaceutical and medtech solutions has announced the launch of its 10th cell and gene therapy (CGT) project. The milestone reinforces Uniphar’s...

Uniphar

- PMLiVE

LEO Pharma and the Parker Institute join forces to advance dermatology research

The alliance will aim to discover molecules that could be incorporated into wider pharmaceutical research

- PMLiVE

Merck and Cyprumed enter oral peptide partnership worth over $493m

The deal gives Merck access to Cyprumed’s drug delivery platform for an undisclosed number of targets

- PMLiVE

GSK’s five-in-one meningococcal vaccine recommended by CDC advisory committee

Penmenvy combines the antigenic components of GSK's approved Bexsero and Menveo vaccines

- PMLiVE

FDA grants interchangeable designation to Celltrion’s Humira biosimilar Yuflyma

The drug is approved for inflammatory conditions such as Crohn's disease and plaque psoriasis

- PMLiVE

The impact of multiple sclerosis on ageing patients

Ageing is associated with significant immunological changes that can influence both the progression of the disease and the response to treatment

- PMLiVE

Petauri unites Mtech Access and Delta Hat under one team: Petauri Evidence

Rapidly growing pharmaceutical services platform unveils new integrated structure for global evidence solutions.

Petauri Evidence

Biogen Idec building

Biogen/Eisai’s Alzheimer’s disease drug Leqembi granted EC approval

The neurodegenerative disorder currently affects an estimated 6.9 million people in Europe

- PMLiVE

Boehringer and Cue partner to advance autoimmune disease candidate in deal worth $357m

The B cell depletion therapy has the potential to reach patients earlier in their treatment journeys

- PMLiVE

Shared decision-making in oncology – turning principles into practice

By Annarita Egidi

- PMLiVE

Reducing disparities in healthcare through shared decision-making

By Alicia Hughes

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links